CNBC's "Fast Money" The Latest U.S.-China Tit-For-Tat… And Fast Money’s Obesity Week Continues 12/3/24
8 snips
Dec 3, 2024 Tensions between the U.S. and China escalate as trade restrictions heat up, but there's talk of potential opportunities in Chinese stocks. The biotech sector shines with innovations in obesity drugs, particularly a promising new treatment entering phase three trials. Insights from major companies like Salesforce and AT&T showcase market shifts driven by AI advancements and strategic investments. The discussion wraps up with analysis on holiday shopping trends and technology's influence on consumer behavior.
AI Snips
Chapters
Transcript
Episode notes
US-China Tensions
- U.S. and China tensions escalate over chip export restrictions and critical mineral bans.
- These minerals, with broad military and consumer uses, haven't been shipped to the U.S. for a couple of years.
Investing Amidst Tensions
- Don't be overly concerned about headlines regarding U.S.-China trade tensions.
- The U.S. has been working on securing rare earth minerals domestically.
China's Priorities
- China prioritizes internal power and social control over external economic perceptions.
- This poses risks for U.S. companies and impacts their long-term strategies.